Key facts
- It has raised $4.1M.
- Notable investors include Enterprise Ireland, Texas Medical Center, Atlantic Bridge Capital, University College Cork, Furthr VC — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for NeuroBell
- ·The full record, as it builds
Funding rounds
No funding rounds for NeuroBell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NeuroBell
Developer of a medical device designed for the early detection and monitoring of seizures in newborn infants. The company's device offers portable and wireless capabilities with real-time seizure alerts, a remote web viewer and benefits such as quick setup and recording by NICU staff and decision support at all times and settings, enabling medical professionals to get quicker diagnoses of neonatal seizures to facilitate improved treatment and patient outcomes.
- Sector
- Healthcare
- HQ
- Cork, Ireland
- Founded
- 2015
- Employees
- 9
- Website
- neurobell.com/
- Ownership
- Privately Held (backing)
NeuroBell doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroBell shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroBell in its N-PORT filings yet. We sweep new filings monthly.